Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study
- PMID: 32479682
- PMCID: PMC7300912
- DOI: 10.1111/1471-0528.16339
Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study
Abstract
Objectives: To investigate the incidence of clinical, ultrasonographic and biochemical findings related to pre-eclampsia (PE) in pregnancies with COVID-19, and to assess their accuracy to differentiate between PE and the PE-like features associated with COVID-19.
Design: A prospective, observational study.
Setting: Tertiary referral hospital.
Participants: Singleton pregnancies with COVID-19 at >20+0 weeks.
Methods: Forty-two consecutive pregnancies were recruited and classified into two groups: severe and non-severe COVID-19, according to the occurrence of severe pneumonia. Uterine artery pulsatility index (UtAPI) and angiogenic factors (soluble fms-like tyrosine kinase-1/placental growth factor [sFlt-1/PlGF]) were assessed in women with suspected PE.
Main outcome measures: Incidence of signs and symptoms related to PE, such as hypertension, proteinuria, thrombocytopenia, elevated liver enzymes, abnormal UtAPI and increased sFlt-1/PlGF.
Results: Thirty-four cases were classified as non-severe and 8 as severe COVID-19. Five (11.9%) women presented signs and symptoms of PE, all five being among the severe COVID-19 cases (62.5%). However, abnormal sFlt-1/PlGF and UtAPI could only be demonstrated in one case. One case remained pregnant after recovery from severe pneumonia and had a spontaneous resolution of the PE-like syndrome.
Conclusions: Pregnant women with severe COVID-19 can develop a PE-like syndrome that might be distinguished from actual PE by sFlt-1/PlGF, LDH and UtAPI assessment. Healthcare providers should be aware of its existence and monitor pregnancies with suspected pre-eclampsia with caution.
Tweetable abstract: This study shows that a pre-eclampsia-like syndrome could be present in some pregnancies with severe COVID-19.
Keywords: Angiogenic factors; COVID-19; PlGF; SARS; SARS-CoV-2; pre-eclampsia; pre-eclampsia-like syndrome; pregnancy; sFlt-1.
© 2020 Royal College of Obstetricians and Gynaecologists.
Figures
Comment in
-
Can COVID-19 in pregnancy cause pre-eclampsia?BJOG. 2020 Oct;127(11):1381. doi: 10.1111/1471-0528.16369. Epub 2020 Jul 20. BJOG. 2020. PMID: 32570284 Free PMC article. No abstract available.
-
Re: Pre-eclampsia-like syndrome induced by severe coronavirus disease 2019: a prospective observational study.BJOG. 2020 Nov;127(12):1577. doi: 10.1111/1471-0528.16402. Epub 2020 Jul 27. BJOG. 2020. PMID: 32716116 No abstract available.
-
Re: Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study: Common pathophysiology of pre-eclampsia and severe COVID-19?BJOG. 2021 Feb;128(3):618-619. doi: 10.1111/1471-0528.16584. Epub 2020 Nov 23. BJOG. 2021. PMID: 33225566 No abstract available.
References
-
- WHO Director‐General's opening remarks at the media briefing on COVID‐19. 2020. [www.who.int/dg/speeches/detail/who‐director‐general‐s‐opening‐remarks‐at...]. Accessed 12 March 2020.
-
- Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, et al. Characteristics of liver tests in COVID‐19 patients. J Hepatol 2020; published online Apr 13. 10.1016/j.jhep.2020.04.006 - DOI
-
- Kreutz R, Algharably EAE‐H, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, et al. Hypertension, the renin‐angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID‐19. Cardiovasc Res 2020; published online Apr 15. 10.1093/cvr/cvaa097 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
